Search

everythinglearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

Both HLA-B and MICA are independently linked to alopecia areata.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Certain genes are linked to the risk of developing Alopecia Areata.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

A gluten-free diet significantly improves skin and health issues in people with dermatitis herpetiformis, a skin condition linked to celiac disease.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.